Peter Noymer

Peter Noymer is the Executive Chairman at PyrAmes, Inc. Peter has previously served as the President and CEO of Kedalion Therapeutics, the EVP and Chief Operating Officer of SteadyMed Therapeutics, and the VP of Product R&D at Alexza Pharmaceuticals. Peter has also worked as a Strategic Advisor / Consultant for various companies.

Peter Noymer has over 20 years of experience in the pharmaceutical industry. Peter is an expert in product development and has played a key role in management teams that have raised over $330 million for various companies. Peter has also been instrumental in securing licensing agreements totaling more than $200 million. In 2018, they were part of the management team that successfully acquired SteadyMed Therapeutics by United Therapeutics.

Peter Noymer completed a BSE in Mechanical & Aerospace Engineering at Princeton University, followed by an MS and PhD in Mechanical Engineering at the Massachusetts Institute of Technology. Peter began their educational career at Marblehead High School.